Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mandy N Lauw

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Hemasphere|March 12, 2026
Extended treatment for venous thromboembolism: Is direct oral anticoagulant dose-reduction better for all?Mandy N Lauw, Saskia Middeldorp, Marc Carrier
The Canadian Journal of Cardiology|April 1, 2014
Recent advances in antidotes for direct oral anticoagulants: their arrival is imminentMandy N Lauw, Michiel Coppens, John W Eikelboom
Seminars in Thrombosis and Hemostasis|October 17, 2013
Cerebral venous thrombosis and thrombophilia: a systematic review and meta-analysisMandy N Lauw, Stefano Barco, Jonathan M Coutinho, et al.
European Heart Journal|February 21, 2014
Heparin bridging in peri-procedural management of new oral anticoagulant: a bridge too far?Thomas Vanassche, Mandy N Lauw, Stuart J Connolly, et al.
Seminars in Thrombosis and Hemostasis|May 1, 2013
Cancer and venous thrombosis: current comprehensions and future perspectivesMandy N Lauw, Frederiek F van Doormaal, Saskia Middeldorp, et al.
Ejhaem|July 6, 2021
COVID-19-associated pseudothrombocytopeniaRuben Van Dijck, Mandy N Lauw, Maurice Swinkels, et al.
Thrombosis and Haemostasis|January 19, 2022
Stroke and Thromboembolism in Patients with Heart Failure and Sinus Rhythm: A Matter of Risk Stratification?Angelica Rivas, Mandy N Lauw, Renate B Schnabel, et al.
Journal of Thrombosis and Haemostasis : JTH|April 4, 2024
A meta-analysis to assess the risk of bleeding and thrombosis following chimeric antigen receptor T-cell therapy: Communication from the ISTH SSC Subcommittee on Hemostasis and MalignancyPoorva Bindal, Rushad Patell, Thita Chiasakul, et al.
Thrombosis and Haemostasis|February 21, 2014
New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusionsNoel C Chan, Jeremy S Paikin, Jack Hirsh, et al.
Journal of Thrombosis and Thrombolysis|November 19, 2014
A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisalNoel C Chan, Deborah Siegal, Mandy N Lauw, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Hemasphere|March 12, 2026
Extended treatment for venous thromboembolism: Is direct oral anticoagulant dose-reduction better for all?Mandy N Lauw, Saskia Middeldorp, Marc Carrier
The Canadian Journal of Cardiology|April 1, 2014
Recent advances in antidotes for direct oral anticoagulants: their arrival is imminentMandy N Lauw, Michiel Coppens, John W Eikelboom
Seminars in Thrombosis and Hemostasis|October 17, 2013
Cerebral venous thrombosis and thrombophilia: a systematic review and meta-analysisMandy N Lauw, Stefano Barco, Jonathan M Coutinho, et al.
European Heart Journal|February 21, 2014
Heparin bridging in peri-procedural management of new oral anticoagulant: a bridge too far?Thomas Vanassche, Mandy N Lauw, Stuart J Connolly, et al.
Seminars in Thrombosis and Hemostasis|May 1, 2013
Cancer and venous thrombosis: current comprehensions and future perspectivesMandy N Lauw, Frederiek F van Doormaal, Saskia Middeldorp, et al.
Ejhaem|July 6, 2021
COVID-19-associated pseudothrombocytopeniaRuben Van Dijck, Mandy N Lauw, Maurice Swinkels, et al.
Thrombosis and Haemostasis|January 19, 2022
Stroke and Thromboembolism in Patients with Heart Failure and Sinus Rhythm: A Matter of Risk Stratification?Angelica Rivas, Mandy N Lauw, Renate B Schnabel, et al.
Journal of Thrombosis and Haemostasis : JTH|April 4, 2024
A meta-analysis to assess the risk of bleeding and thrombosis following chimeric antigen receptor T-cell therapy: Communication from the ISTH SSC Subcommittee on Hemostasis and MalignancyPoorva Bindal, Rushad Patell, Thita Chiasakul, et al.
Thrombosis and Haemostasis|February 21, 2014
New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusionsNoel C Chan, Jeremy S Paikin, Jack Hirsh, et al.
Journal of Thrombosis and Thrombolysis|November 19, 2014
A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisalNoel C Chan, Deborah Siegal, Mandy N Lauw, et al.
Pageof 4